Search results for "FDA update"
First drug in new class approved
The FDA recently approved canaglifozin (Invokana) tablets to improve glycemic control in adults with type 2 diabetes, along with diet and exercise.
https://diabetes.acponline.org/archives/2013/06/14/10.htm
14 Jun 2013
New contraindication for aliskiren-containing medications
Aliskiren-containing medications are contraindicated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with diabetes.
https://diabetes.acponline.org/archives/2012/07/13/10.htm
13 Jul 2012
New long-acting insulin drugs approved
Insulin degludec injection (Tresiba) and insulin degludec/insulin aspart injection (Ryzodeg 70/30) were approved by the FDA on Sept. 25.
https://diabetes.acponline.org/archives/2015/10/09/8.htm
9 Oct 2015
Combo of metformin and dapagliflozin approved
A once-daily combination pill of dapagliflozin and metformin HCl extended-release (Xigduo XR) was recently approved by the FDA.
https://diabetes.acponline.org/archives/2014/11/14/8.htm
14 Nov 2014
Aflibercept approved for diabetic retinopathy in diabetic macular edema
Aflibercept (Eylea) has received expanded approval to treat diabetic retinopathy (DR) in patients with diabetic macular edema (DME), the FDA recently announced.
https://diabetes.acponline.org/archives/2015/04/10/7.htm
10 Apr 2015
Glucose monitoring app, weight-loss device, medications approved
The FDA approved an app for continuous glucose monitoring, a weight-loss device, a combination diabetes pill, and a new indication for an eye medication in the past month.
https://diabetes.acponline.org/archives/2015/02/13/7.htm
13 Feb 2015
Alert warns about cybersecurity risk with insulin pump system
A potential issue with the Medtronic MiniMed 600 Series Insulin Pump System's communication protocol could allow unauthorized access to the device, the FDA said.
https://diabetes.acponline.org/archives/2022/10/14/9.htm
14 Oct 2022
New labels warn against sharing multi-dose insulin pens
In an effort to reduce the risk of infection spread, the FDA recently required additional label warnings about sharing of multi-dose diabetes pen devices, which are intended for single patient use only.
https://diabetes.acponline.org/archives/2015/03/13/9.htm
13 Mar 2015
New drug approved, meters recalled
Dapaglifozin (Farxiga), a new medication to treat type 2 diabetes, was recently approved by the FDA for use along with diet and exercise.
https://diabetes.acponline.org/archives/2014/03/14/7.htm
14 Mar 2014
Olmesartan passes safety review
The benefits of the angiotensin-receptor blocker olmesartan continue to outweigh the risks for diabetic patients, according to the FDA.
https://diabetes.acponline.org/archives/2014/07/11/8.htm
11 Jul 2014